Will patients act on results of germline genome sequencing?
Australian study reveals what people will do if they find out they have an increased heritable cancer risk
People with cancer and their relatives awaiting germline genome sequencing show high levels of intention to modify their behaviour if a gene variant linked to malignancy is detected, an Australian study shows.
But many of them have an incomplete understanding of germline genome sequencing (GS), over-estimating the likelihood of obtaining an actionable result, the Australian researchers say.
